Zurich, Switzerland

Kathrin Schwager

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Aadorf, CH (2016 - 2018)
  • Zurich, CH (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Kathrin Schwager: Innovator in Rheumatoid Arthritis and Inflammatory Bowel Disease Treatments

Introduction

Kathrin Schwager, an accomplished inventor based in Zurich, Switzerland, has made significant strides in the fields of rheumatoid arthritis and inflammatory bowel disease (IBD). With a total of nine patents to her name, Schwager is recognized for her impactful contributions to medical research and innovation.

Latest Patents

Among her latest patents, one notable invention focuses on an antigen associated with rheumatoid arthritis. This innovative work pertains to a binding member that specifically targets the Extra Domain-A (ED-A) isoform of fibronectin. This development holds promise for advancing detection and treatment methods for individuals suffering from rheumatoid arthritis. Another significant patent from Schwager involves anti-ED-A immunoconjugates intended for IBD. This invention details specific binding members that can bind to the ED-A isoform of fibronectin, facilitating improved diagnostic and treatment options. These binding members can be conjugated with immunosuppressive or anti-inflammatory molecules, such as interleukin-10, which can be delivered directly to the affected IBD tissue.

Career Highlights

Kathrin Schwager's career is marked by her dedication to innovative research and development within the biomedicine sector. Currently, she is affiliated with Philogen S.p.a., a company renowned for its focus on developing therapeutic products based on tumor-targeting technologies. Her work is pivotal in efforts to enhance patient care and treatment efficacy.

Collaborations

Throughout her career, Schwager has collaborated with esteemed colleagues, including Manuela Kaspar and Eveline Trachsel. These partnerships leverage collective expertise, resulting in enhanced innovation and progress in their respective research endeavors.

Conclusion

Kathrin Schwager exemplifies the impact that dedicated inventors can have on medical advancements. With her innovative patents targeting rheumatoid arthritis and inflammatory bowel disease, she is paving the way for new treatment possibilities that will benefit countless patients. As her work continues to evolve, the medical community looks forward to the potential breakthroughs that may arise from her research and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…